Completed PHASE1 INTERVENTIONAL 1-arm NCT01581411

Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion

Phase 1 Trial of Intra-Ophthalmic Artery Thrombolysis for Treating Recent Severe Central Retinal Vein Occlusion

Sponsor: Weill Medical College of Cornell University

Conditions Central Retinal Vein Occlusion

Interventions Tissue Plasminogen Activator

Updated 7 times since 2017 Last updated: Aug 2, 2018 Started: Jan 31, 2012 Primary completion: Nov 30, 2015 Completion: Nov 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Central Retinal Vein Occlusion and is currently completed. Weill Medical College of Cornell University leads this study, which shows 7 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Sep 2018 — Jan 2021 [monthly]

Completed PHASE1

Status: Unknown Status → Completed
Jun 2018 — Sep 2018 [monthly]

Unknown Status PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE1
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE1

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Weill Medical College of Cornell University

Data source: Weill Medical College of Cornell University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States